Relay Therapeutics, Inc.
-
Ticker
RLAY
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Cambridge, Massachusetts
Relay Therapeutics is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. As the first of a new breed of biotech created at the intersection of complementary techniques and technologies, Relay Therapeutics aims to push the boundaries
…More of what’s possible in drug discovery. Its Dynamo™ platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Relay Therapeutics’ initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications.
REPORT RATINGS
5.0 / 5.0 (1)
Relay Therapeutics, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.
Relay Therapeutics, Inc.
Most Recent Responsibility Report
MOST RECENT
2023 Corporate Responsibility Report
Report Locked. Relay Therapeutics, Inc. has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Relay Therapeutics, Inc. Sustainability Report, Relay Therapeutics, Inc. Corporate Social Responsibility Report, Relay Therapeutics, Inc. CSR Report, Relay Therapeutics, Inc. Corporate Responsibility, Relay Therapeutics, Inc. CR Report, Relay Therapeutics, Inc. Citizenship Report, Relay Therapeutics, Inc. ESG Report, and Relay Therapeutics, Inc. Environmental Report online.